Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
Recent evidence suggests that neural stem/precursor cells (NPCs) promote recovery in animal models with delayed neuronal death via a number of indirect bystander effects. A comprehensive knowledge of how transplanted NPCs exert their therapeutic effects is still lacking. Here, we investigated the effects of a delayed transplantation of adult syngenic NPCs--injected intravenously 72 h after transient middle cerebral artery occlusion--on neurological recovery, histopathology and gene expression. NPC-transplanted mice showed a significantly improved recovery from 18 days post-transplantation (dpt) onwards, which persisted throughout the study. A small percentage of injected NPCs accumulated in the brain, integrating mainly in the infarct boundary zone, where most of the NPCs remained undifferentiated up to 30 dpt. Histopathological analysis revealed a hitherto unreported very delayed neuroprotective effect of NPCs, becoming evident at 10 and 30 dpt. Tissue survival was associated with downregulation of markers of inflammation, glial scar formation and neuronal apoptotic death at both mRNA and protein levels. Our data highlight the relevance of very delayed degenerative processes in the stroke brain that are intimately associated with inflammatory and glial responses. These processes may efficaciously be antagonized by (stem) cell-based strategies at time-points far beyond established therapeutic windows for pharmacological neuroprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, beneficial effects were reported even when treatments were initiated days, weeks, or months after stroke.14–20”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“In addition to the sprouting of pyramidal tract fibres, remodelling of transcallosal projections connecting the two motor cortices occurs.14,25”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“By contrast with neuroprotection, which requires an acute intervention, treatments promoting neurological recovery by remodelling of brain tissue can be instituted during the stroke recovery phase.10–15”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“Microvessels and neuroblasts mutually support each other via release of trophic factors, resulting in a tight interplay that stimulates brain remodelling processes, reducing delayed neuronal degeneration,14,45 promoting neuronal plasticity,15 modulating glial responses,14,46 and attenuating brain inflammation14,46 (figure 2).”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
In the citing paper
“The finding that neural precursor cells prevent ischaemic injury and promote neurological recovery could be attributed to bystander effects related to the interaction of neuroblasts with the microvasculature in the vicinity of the ischaemic lesion, which creates an environment that promotes brain remodelling (figure 2).14,15,37,45”
From Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation (2012) · cites this paper as [14]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 2×
“This might imply that therapies favouring endogenous tissue repair and/or remodelling may have realistic chances of success also when applied beyond established time-windows of tissue protection, which in the case of thrombolytics in humans are in the range of 3–6 h (Hacke et al., 2008).”
BackgroundPathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943 · cited 1×
“In the ischaemic border zone surrounding the evolving infarct, inflammatory responses and apoptotic programs are activated in this phase that further contribute to injury development (Dirnagl et al., 1999; Hermann et al., 2001; Hossmann, 2006).”
BackgroundWest, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994 · cited 2×
“Forty-five minutes of MCAO were induced in adult male 8- to 10-week old (weight 20–25 g) C57Bl/6 mice (Harlan Nossan, Netherlands), as previously described (Hata et al., 2000; Hermann et al., 2001).”
MethodInfluentialSelf-citationThe glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 2×
“Following the acute stroke phase, the tissue undergoes substantial matrix remodelling that results in (astro)glial scar formation, which is widely regarded as a major hampering factor for tissue repair and regeneration (Fawcett and Asher, 1999; Nedergaard and Dirnagl, 2005; Yiu and He, 2006).”
BackgroundInfluentialGlial inhibition of CNS axon regeneration
Yiu, G., & He, Z. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1956 · Cited by 1,495 · cited 2×
“Gliotic scar formation is regarded as a major factor hampering recovery from stroke (Li et al., 2005; Yiu and He, 2006).”
BackgroundInfluentialRegulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115 · cited 1×
“Further, the importance of both TNF- and IFN-g is emphasized by the demonstration that antagonization of the production of either of these inflammatory cytokines significantly prevented secondary infarct growth after stroke (Liesz et al., 2009).”
BackgroundInjection of adult neurospheres induces recovery in a chronic model of multiple sclerosis
Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., et al. (2003) · Nature · doi:10.1038/nature01552 · Cited by 1,068 · cited 3×
“Key functions such as the replacement of neural cells (Pluchino et al., 2003; Karimi-Abdolrezaee et al., 2006) and the delivery of therapeutic gene(s) (Lee et al., 2007) have been recently challenged by intrinsic bystander capacities, mainly exerted by undifferentiated NPCs, releasing at the site…”
BackgroundMethodInfluentialSelf-citationInterleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992 · cited 2×
“(Barone et al., 1997; Hallenbeck, 2002; Allan et al., 2005) that contribute to the detrimental post-ischaemic brain inflammation in”
BackgroundCentral nervous system injury-induced immune deficiency syndrome
Meisel, C., Schwab, J. M., Prass, K., Meisel, A., & Dirnagl, U. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1765 · Cited by 968 · cited 2×
“…rather than immune-suppressive action exerted by NPCs may be of pivotal interest as stroke is accompanied by an early peripheral immunodeficiency phase (Meisel et al., 2005; Offner et al., 2006; Offner et al., 2009) that limits the application of systemic immunosuppressive therapies.”
BackgroundActivation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia
Namura, S., Zhu, J., Fink, K., Endres, M., Srinivasan, A., Tomaselli, K. J., Yuan, J., & Moskowitz, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-10-03659.1998 · Cited by 893 · cited 3×
“That the therapeutic window is so narrow has been explained by the fact that brain infarct evolves very rapidly, typically within a few hours up to 3–4 days after stroke, depending on the duration and severity of ischaemia (Garcia et al., 1993; Namura et al., 1998; Hata et al., 2000; Li et al., 2000; Hermann et al., 2…”
BackgroundInfluential
Cited by
Items 301–350 of 350
Nunzio, M. D., Mignogna, M. L., Bacigaluppi, M., Panina‐Bordignon, P., Ragonese, P., Muzio, L., Summa, V., & Martino, G. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107194 · Cited by 3
Self-citationApplication of emerging technologies in ischemic stroke: from clinical study to basic research
Chen, Q., Zhang, S., Liu, W., Sun, X., Luo, Y., & Sun, X. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1400469 · Cited by 5
Payne, S. L., Ballios, B. G., Baumann, M. D., Cooke, M. J., & Shoichet, M. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00068-0 · Cited by 5
Liu, S., Li, Z., Fu, J., Sun, L., Xu, F., Harada, T., Lou, Y., Chu, M., Sun, Q., Xu, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107865 · Cited by 2
Stem cell therapies for neuropathic pain
Seewoodhary, J., & Harvey, J. N. (2014) · The British Journal of Diabetes · doi:10.15277/bjdvd.2014.002 · Cited by 2
Mesenchymal Stromal Cell Secretome for Tissue Repair
Gnecchi, M., Ciuffreda, M. C., & Mura, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-37076-7_43-1 · Cited by 3
Bench-to-Bedside Translation of Stem Cell Therapies: where are we now and where are we Going?
Martino, G. (2016) · Regenerative Medicine · doi:10.2217/rme-2016-0041 · Cited by 2
Self-citationKim, H. J., Kim, D. H., Choi, J. I., Sim, H., Jung, S., Hwang, D., & Kim, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650092 · Cited by 2
Intra-arterial Cell Therapy in Stroke Patients
de Freitas, G. R., & Méndez‐Otero, R. (2012) · Springer eBooks · doi:10.1007/978-3-7091-1175-8_13 · Cited by 1
Viral Manipulation of Neural Stem/Precursor Cells
Iraci, N., Tyzack, G. E., Cossetti, C., Alfaro‐Cervelló, C., & Pluchino, S. (2013) · Neuromethods · doi:10.1007/978-1-62703-610-8_14 · Cited by 1
Co-transplantation Strategies and Combination Therapies for Stroke
Popa‐Wagner, A., Sandu, R. E., & Ciobanu, O. (2016) · Springer eBooks · doi:10.1007/978-981-10-2929-5_8 · Cited by 2
Hype and Hopes of Stem Cell Research in Neurodegenerative Diseases
Sharma, N. K., Mathur, D., Vinish, M., Sharma, R., Bhatia, K., Pannu, V. S., & Anand, A. (2017) · Springer eBooks · doi:10.1007/978-981-10-3701-6_13 · Cited by 1
Exosomes: Natural Nanoparticles with Therapeutic Potential
Ratushnyak, M. G., & Semochkina, Y. P. (2020) · Nanotechnologies in Russia · doi:10.1134/s1995078020040126 · Cited by 1
Glycoconjugate for Tissue Engineering
Wihadmadyatami, H., & Kusindarta, D. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-35734-4_60-1 · Cited by 1
Glycoconjugate for Tissue Engineering
Wihadmadyatami, H., & Kusindarta, D. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-42215-8_60 · Cited by 1
Towards Clinical Application of Stem Cells in Neurodegenerative Disorders
Lindvall, O., & Kokaia, Z. (2010) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-60761-959-8_1 · Cited by 1
Low Immunogenic Potential of Human Neural Stem Cells
De, L., Rota, L., & Gelati, M. (2012) · InTech eBooks · doi:10.5772/26532 · Cited by 1
“…as secretion of neurotrophic factors and cytokines, scavenging of toxic molecules, immunomodulation of inflammatory milieu, where neural cell replacement plays only a minor role in the recovery of CNS damage (Bacigaluppi et al. 2009;Behrstock et al. 2006;Ebert et al. 2008;Lindvall and Kokaia 2010).”
BackgroundCell Therapy in Ischemic Stroke
Misra, V., & Savitz, S. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00039-4 · Cited by 1
Stem Cell Transplants in the Aged Stroke Brain: Microenvironment Factors
Popa‐Wagner, A., & Napoli, M. D. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_3 · Cited by 1
Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis
Bonab, M. M., Shakiba, Y., Talebian, F., & Nikbin, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800763-1.00017-8 · Cited by 1
Regenerative Medicine of Neural Tissues
Stocum, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384860-4.00011-3 · Cited by 2
Park, K. I. (2011) · Journal of Korean Medical Association · doi:10.5124/jkma.2011.54.5.468 · Cited by 1
Dual role of brain endothelial Gpr126 in blood-brain barrier development and ischemic strokePreprint
Kakogiannos, N., Scalise, A. A., Martini, E., Maderna, C., Magni, S., Gullotta, G. S., Lampugnani, M. G., Iannelli, F., Beznoussenko, G. V., Aa, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.09.507316 · Cited by 1
“Behavioral analysis: The modified Neurological Severity Score (mNSS) grades neurological function was used, for a scale of 0 to 12 (normal score 0; maximal deficit score 12). mNSS is a composite of motor and balance tests (Bacigaluppi et al., 2009).”
MethodInfluentialSelf-citationBrain Repair: The Role of Endogenous and Transplanted Neural Stem Cells
Bacigaluppi, M., Butti, E., Laterza, C., Feo, D. D., Peruzzotti‐Jametti, L., Merlini, A., Cusimano, M., & Martino, G. (2014) · Wiley eBooks · doi:10.1002/9781118406557.ch5
Self-citationCurrent Status and Therapeutic Perspectives for the Stem Cells Treatment of Ischemic Stroke
Kim, H. (2012) · Hanyang Medical Reviews · doi:10.7599/hmr.2012.32.3.134
Host responses to human neural cell therapy in spinal cord injury
Liu, J. S. (2013) · Figshare
Changes in Neural Stem Cells in Neonatal Rats with Hypoxic-ischaemic Encephalopathy
Zc, F., Liu, J., & Ju, R. (2012)
Kim, H. J. (2014) · eScholarship (California Digital Library)
Role of Biomaterials in Neural Stem Cell Fate
K.S., P. C. S. (2015) · Global Journal of Human Social Science
Wang, J. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Blood Vessel Remodeling After Stroke
Moralí, G., & Cervantes, M. (2015) · CRC Press eBooks · doi:10.1201/b18028-9
Gene Modified Stem/Progenitor‐Cell Therapy for Ischemic Stroke
Li, Y., Yang, G., & Wang, Y. (2016) · Wiley eBooks · doi:10.1002/9781119135449.ch18
Modification of Bone Marrow Stem Cells for Homing and Survival During Cerebral Ischemia
Tang, Y. (2016) · Springer eBooks · doi:10.1007/978-981-10-2929-5_9 · Cited by 1
“These factors include but not limited to time after injury [47], distance from the transplantation site to the lesion site [86], state of the cells transplanted (differentiated or undifferentiated) [59], aging of the cells transplanted [108], host immune response [35], and phagocytic response of host [2].”
BackgroundBone-Marrow-Derived Cell Therapies in Stroke: Immunomodulatory Effects
Maali, L. N., & Hess, D. C. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-66679-2_9
The stem cell secretome and its role in brain repair q
Drago, D., Cossetti, C., Iraci, N., Gaude, E., Musco, G., Bachi, A., & Pluchino, S. (2013)
Kılıç, Ü., Elibol, B., Çağlayan, A. B., Beker, M. Ç., Beker, M., Altuğ, B., Uysal, Ö., Yılmaz, B., & Kılıç, E. (2020) · Research Square · doi:10.21203/rs.3.rs-45391/v1
Zheng, X. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9092
Subventricular zone cytogenesis provides trophic support for neural repairPreprint
Williamson, M. R., Le, S., Franzen, R. L., Donlan, N. A., Rosow, J. L., Dunn, A. K., Jones, T. A., & Drew, M. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.14.496078
“…and in diverse disease settings have been reported to express trophic factors, which may be implicated in their therapeutic effects (Andres et al., 2011; Bacigaluppi et al., 2009; Drago et al., 2013; Horie et al., 2011; Llorente et al., 2021; Martino and Pluchino, 2006; Roitbak et al., 2011).”
BackgroundCell-Mediated Neurorestorative Mechanisms Underpinning Beneficial Effects in Ischemic Stroke
Siddiqui, A. J., Prakash, R., Fatima, A., Fatima, A., Khan, A. Q., & Raza, S. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-8562-0_4
Review article: Paracrine effects of Transplanted Neural stem cells in Ischemic strokes
Al-kaabi, M. M., & Al-Rubai, A.-J. F. (2021) · Iraqi Journal of Cancer and Medical Genetics · doi:10.29409/ijcmg.v14i1.322 · Cited by 1
Kanazawa, M., Hatakeyama, M., & Ninomiya, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00090-1 · Cited by 1
Stem cell for PD: Technical considerations
Ibrahim, S. S., Elmligy, E., & Tharwat, E. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00008-6
Yin, D., Wang, C., Qi, Y., Wang, Y.-C., Hagemann, N., Yusuf, A. M., Dzyubenko, E., Kaltwasser, B., Tertel, T., Giebel, B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151209
Self-citationDilsiz, P., Ozpinar, A., Balaban, B., Koç, H. I., Altunay, S., Baltacı, S. B., Hapil, F. Z., Doeppner, T. R., Dzyubenko, E., Beker, M. Ç., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08536-0 · Cited by 1
“Considering that vasoconstriction-associated CBF reduction may protect the brain against neuronal injury by reducing oxidative stress [48, 49], we next examined if chemogenetic DMH VGAT silencing in fl uenced post-ischemic reperfusion.”
Self-citationFriec, A. L. (2020) · theses.fr (ABES) · doi:10.70675/2412aa7cz73eez4ce3za0f4z1529f930f5f4 · Cited by 2
Nyarkoh, J. K., Asiamah, E. A., Nyarko, S. B., Boachie, J., Dzuvor, C. K. O., Kotam, G. P., Larnyoh, M. T., Mawunyo, A. O., & Nyarko, B. (2026) · Neurology Research International · doi:10.1155/nri/9430707
“Evidence from delayed transplantation and chronic stroke models indicates that reductions in infammatory markers often decline at later stages [71–74].”
Alfaro‐Cervelló, C., Cossetti, C., Giusto, E., Donegà, M., & Pluchino, S. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-098-4_2
Metadata
- Authors
- Bacigaluppi, M., Pluchino, S., Jametti, L. P., Kilic, E., Kilic, Ü., Salani, G., Brambilla, E., West, M. J., Comi, G., Martino, G., & Hermann, D. M.
- Affiliations
- University Hospital Zurich (CH)
- IRCCS Ospedale San Raffaele (IT)
- Aarhus University (DK)
- Corresponding author
- Hermann, Dirk M.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-07-16
- Volume
- 132
- Issue
- 8
- Pages
- 2239-2251
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117381245
- Cited by
- 350
- References
- 59
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 8 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 26 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 29 · 2015: 27 · 2014: 33 · 2013: 29 · 2012: 32
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (112056, 3200B0)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- neural stem cell transplantation, ischemic stroke, middle cerebral artery occlusion, bystander effect, neuronal apoptosis, glial scar formation, neuroinflammation, delayed neuronal death, neurological recovery, gene expression
- MeSH terms
- Animals, Astrocytes, Atrophy, Brain, Cell Survival, Cicatrix, Corpus Callosum, Disease Models, Animal, Gene Expression Regulation, Inflammation, Male, Mice, Inbred C57BL, Neurons, Disease Progression, Stroke, Gene Expression Profiling, Stem Cell Transplantation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.